Tag: China

Gastric Cancer – Global Drug Forecasts And Treatment Analysis To 2020 Volume I 2011

Posted on by admin

GlobalData analysis finds that the global gastric cancer therapeutics market is attractive, and is primarily driven by the growth in the number of patients receiving gastric cancer therapy and the annual cost of therapy. The patient volume is primarily driven by an increase in patient volume in countries such as China, France, Spain and Italy. The patient volume was driven by growth in treatment usage patterns such as diseased population, treatment seeking population, diagnosis population and prescription population. The annual cost of gastric cancer therapy was driven by the launch of new therapies such as Taxotere (docetaxel), Xeloda (capecitabine) and Herceptin (trastuzumab).

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Gastric-Cancer-Global-Drug-Forecasts-and-Treatment-Analysis-to-2020-Volume-1-2011&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report

There is no standard care for gastric cancer. The treatment of gastric cancer is largely based on the treatment guidelines of different countries. Very few drugs are actually approved for gastric cancer, although many drugs are recommended for use
in treatment. Taxotere is approved as a first line therapy in gastric cancer. The introduction of new therapies for metastatic gastric cancer is expected to expand the market further.

In 2010, Japan was the leading market in the global gastric cancer therapeutics market with an estimated market share of approximately 24.7%. China was the second leading market with 17% market share. The US is the third largest gastric cancer market with a 15% market share. Japan and China lead the market due to a large patient base.

In 2010, Taxotere was the leading drug with approximate sales worth $170m and a market share of 30%. Herceptin, which was launched in the US and EU in 2010, is expected to gain market share in the forecast period 2010-2020.

GlobalData, the industry analysis specialist, has released its new report, Gastric Cancer – Global Drug Forecasts and Treatment Analysis to 2020 Volume I 2011. The report is an essential source of information and analysis on the global gastric cancer therapeutics market. The report provides comprehensive information on gastric cancer, highlighting the treatment guidelines. It identifies and analyses the key trends shaping and driving the global gastric cancer therapeutics market. It analyses the treatment usage patterns in the global gastric cancer therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. The report provides valuable insights into the pipeline products within the global gastric cancer sector. It quantifies the unmet need in the global gastric cancer therapeutics market as well as in the individual markets such as the US and the top five countries in Europe, highlighting the opportunity for future players

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Gastric-Cancer-Global-Drug-Forecasts-and-Treatment-Analysis-to-2020-Volume-1-2011&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Pharmaceuticals_and_Healthcare

Visit our report store: http://www.globaldata.com

For more details contact:
[emailprotected]
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

China Healthcare Sector Analysis

Posted on by admin

China’s healthcare industry is entering into a new era with advance development of the infrastructure system. The industry is blessed with several advantages like large population of the country, increasing ageing population, increasing prevalence of lifestyle disease and many more. The government has also boosted the industry growth by blessing the sector with a US$ 120 Billion reform package. Backed by these all factors, healthcare sector in China is expected to outperform all other sectors in the country in terms of growth.

According to our new analytical study on the sector called -China Healthcare Sector Analysis- the China healthcare spending is forecast to grow at CAGR of over 18% during 2010-2012. Currently, the market is characterized by major changes in rural healthcare infrastructure. Anticipating the future growth, many private sector giants are looking to invest in the sector to get a pie of the chunk.

Our report has found that medical device market is expected to grow most in all other segments. The government decision to improve the healthcare infrastructure in rural areas will result in increasing demand of medical devices and equipments. Backed by this increasing demand, the medical device market is expected to grow at a CAGR of around 20% during 2010-2012. In this regard, our report provides rational analysis of various factors which will drive this market segment over the forecast period.

It also provides extensive information on Chinese pharma market with the detailed description of traditional Chinese medicines and western medicine market. It also highlights several emerging market trends like medical tourism market, healthcare IT market, telemedicine, etc. The research study gives detailed statistical and analytical review on demographics, macroeconomic indicators, disease profile, healthcare services market, key drivers and restraints. It contains all the vital information that will help clients to draw up their market strategies and assess opportunity areas in China’s healthcare market.

For FREE SAMPLE of this report visit:

Check DISCOUNTED REPORTS on:

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today’s globally competitive environment.

Chinese Medicine Import And Export Volume Increased 5-fold In Ten Years

Posted on by admin

Since accession to the WTO in 2001, China’s pharmaceutical trade gained rapid development. Chinese medicine trade in 2001 totaled only $ 9.5 billion, by 2010 this figure had reached $ 60.2 billion, an increase of over 10 years ago, more than 5 times. Among them, the imports increased from $ 4.1 billion to 205 billion U.S. dollars, about 20% compound annual growth rate of exports from 54 billion dollars to nearly $ 40 billion, the annual compound growth rate of 25%, import and export growth in excess of the overall foreign trade level.
Decades, China’s pharmaceutical market continues to expand foreign trade, import and export growth in the country from 196 to 221, covering almost all the world’s countries (regions). In addition, Chinese medicine to optimize the export structure, formed bulk drug products, based on high-tech products export-oriented development model. As Chinese medicine raw materials industries, the pharmaceutical exports has always been dominant, ten years exports increased from $ 2.8 billion to 203 billion dollars, saccharin sodium, vitamin C, penicillin industrial salt, vitamin E and drugs paracetamol and other bulk materials exports have accounted for 90% of world trade, 65%, 60%, 44% and 40%.
Decades, China’s pharmaceutical market, the main foreign trade has undergone profound changes, plant extracts from a state-led, foreign investment, supplemented by private and other business structures gradually changed to private, foreign-led, diverse forms of ownership and common development of a new pattern. Among them, the state-owned enterprise market share from 60% in 2001 decreased significantly from 20% in 2010, foreign-funded enterprises rose from 32% to 42%, private enterprises increased from less than 8% to 37%.
Accession to the WTO, China has significantly improved the overall environment of pharmaceutical trade, but with the foreign markets, the removal or reduction of tariff barriers, technical barriers and trade frictions over the rise before the WTO, also significantly increased the difficulty of response.
Deal with technical barriers to trade in, since 2001, Health Insurance Association several times through international dialogue, reflect the demands and maintain industry interest. Registration Act for the EU’s traditional medicine in Chinese exports may cause serious obstruction problems, Health Insurance Association on behalf of domestic industry under the framework of trade barriers through the WTO notification mechanism for formal concerns and views of the industry, causing the EU to focus on and respond, To properly resolve relevant issues played a positive role.
In response to trade friction, the decade of the lead in organizing the Chamber of Commerce over 30 foreign anti-dumping and safeguard measures responding to the survey work, and has launched an industry representative organizations as injury defense. Tartaric acid in the EU anti-dumping cases on me, resveratrol including many cases, some of the companies involved to a zero tax rate for the ruling, or the investigating authorities to reach a reasonable quantity / price promise settlement.
Overall, pharmaceutical trade friction cases in the WTO the following characteristics: First, no significant increase in the number of incidence; the second is involved in product exports hit record highs, including penicillin industrial salt for me in India and 6-APA-sponsored anti-dumping investigations involving more than $ 200 million, China’s pharmaceutical industry is by far the anti-dumping cases involving the highest amount; third country to initiate an investigation was the diversity, the emerging pharmaceutical markets such as Brazil, Russia, Argentina and other pharmaceutical products, I have initiated anti-dumping or safeguard measures, pharmaceutical raw materials while traditional markets such as the European Union, China, India and other trade remedy cases as the main sponsors of the situation has not changed, the overall trade friction involved into diversified country; four is involved in drug products from raw materials to medical device extension of the field, including patient monitors, including the high-tech medical products become the new target of investigation.

Replica Industry Review

Posted on by admin

The replica industry has been around for a long time. Depending on if you have the know-how, this industry can actually be a very profitable one. It is illegal to sell replicas as if they are the real brands in most developed countries. However, if you are honest about what you are selling, and do not copy the brand name exactly, the replica industry is perfectly legal and legitimate. It is also one of the few industries that is recession-proof. The replica watch industry actually recorded an increase in profit during the recession, since most people could no longer afford designer accessories, yet still wanted to maintain their lifestyle.

Some replicas are very poorly made. If you decide to invest in replicas that make it painfully obvious that they are knock-offs, then you probably will not make a lot of money. Replicas need to be made so that they are practically identical to the real thing. Well-made replicas make it impossible to tell the difference between a real thing and a knock-off unless you examine the actual materials of the item up close. If your replicas are almost identical to the real thing, then you could make good money from investing in the replica industry.

However, it is illegal to use a companys trademarked brand name. It is also illegal to use a watchs design. Both these traits are copyrighted to the watchs original manufacturer. It is estimated that the replica industry causes a one to three billion dollar loss per year to the real manufacturers. The majority of replica items are made in China. Some are made with some precious metals and materials (like gold and leather) and these are known as “high-end replica.” Others are not made with any precious materials and are known as “low-end replica.” Sometimes the replica are cheaper than the brand name by a very significant amount, and sometimes replica are only cheaper than the brand name by a little bit. The latter is the one that is usually marketed (falsely) as the real deal.

Those who are successful in the replica industry must be very fashion-savvy and must have a good understanding of the fashion-industrys constantly evolving trends. The whole point of replicas is so that the individual can be a part of the most recent fashion styles. No one wants a replica of last seasons fashions, or last years “it” item. They also need access to the real products in order to be able to fashion something very similar to it. It is hard to make a copy of a product simply by looking at its pictures. High-end replica makers usually have the brand name product and mimic it very carefully and thoroughly.

The replica industry is a multi-billion dollar a year industry. It is illegal in some countries, but completely legitimate in others. Most people will avoid breaking their local laws by purchasing their replica items online. Since there are no copyright laws in other countries, purchasing from them is technically legal.

Acupuncture an Alternative Medicine

Posted on by admin

Acupuncture is often associated with pain control; in the hands of a well-trained practitioner, it has much broader applications. Acupuncture is a part of the health care system of China that can be traced back at least 2,500 years. The general theory of acupuncture is based on the premise that there are patterns of energy flow (Qi) through the body that are essential for health. Disruptions of this flow are believed to be responsible for disease. The goal of this procedure is to restore the well-being and the health of the individual. While it may seem strange, acupuncture uses a method of inserting needles into specific points in the body. It should only be performed by a skilled individual, one that has received training in the. It is a method of encouraging the body to promote natural healing and to improve functioning. Acupuncture can be effective as the only treatment used, or as the support or adjunct to other medical treatment forms in many medical and surgical disorders. One should always plan their activities so that after the treatment one can get some rest. This is especially important for the first few visits. Do not eat an unusually large meal immediately before or after the treatment.

With increased globalization and exchange of views and other parameters, the system of medicine also attempts to enter into the others territories. It is an ongoing process, which results in giving world class treating mechanisms and ultimately results in better way of healing. As there are many cases that represent the audacity of the claim of treating by one system of medicine establishing itself as superior, yet there are no guarantees that a particular medicine system will eventually succeed in giving relief to the patient. However, there are attempts that go on in justifying the superiority of a particular medicine system and it applies to all the healing systems of the world. In fact, it is primarily the result of enhanced globalization.

Some of the people on the western side of the fence think that Chinese Medicine is confined to magic and associate it with being hocus-pocus. They see it primitive and since the basis of Chinese Medicine owes its origins to herbs or acupuncture, it is largely related to one of yet another term, placebo effect. Chinese Medicine is largely taken upon as non-working when it comes to serious cure and genuine diseases or illnesses. Moreover, Chinese Medicine is taken as ancient leaning towards spiritualism, and more taken as falling in the category of religious healing practices.

However, the fact of the matter is entirely different. Chinese Medicine is actually coherent and independent system of thought and practice that took quite a long time to evolve and reach the current stage. Chinese Medicine approaches the human body and attempts to restore it with an progress understanding and curing skills. That is where it is gaining immense popularity not only in the areas where it is already established but also in the far-flung world regions.

Healthcare Industry China Animal Feed Industry Research Report

Posted on by admin

Animal products such as meat, milk and eggs are an expensive source of food as compared to stable crops. Due to this, the consumption of animal protein in the developing nations is well below the world average. However, the transition in the economies of these countries has lead to growth in disposable income, purchasing power and the consequential rise in demand for animal protein. Food consumption level is now considered a clear indicator of the size of a country’s population and the health of its economy. China is by far the best example to highlight the validity of this point.

China continues to develop and is rapidly becoming a stronger economy. The sophistication and rising standard of living of the population has resulted in a change in dietary patterns. China is the world’s largest consumer of meat and is nearly self sufficient in meeting its requirements. Livestock production has been growing faster than any other agricultural sub-sector in China in recent decades, mainly due to the substantial growth of pig and poultry industries. To support its large number of livestock, the country requires animal feed in quantity and quality. This is the most important reason behind the growth of the animal feed industry in China.

The 6 broad categories of animal species for which feed is specifically manufactured in China are pig, boiler poultry, layer poultry, aquatic animals, ruminant and feed for other animals such as horses and pets. Since China is the largest market in the world for pork, pig feed is the major segment within animal feed in the country. Furthermore, the consumption of chicken is increasing rapidly, thereby amplifying demand for boiler poultry. However, feed for aquatic species is the fastest growing segment owing to the booming aquaculture sector in China.

-Due to the development of China’s economy, the population is increasingly being able to afford animal protein and is constantly adding the same to their diets. Subsequently, animal feed is required both in quantity and in quality to support the livestock in the country.– according to the research report -China Animal Feed Industry Review to 2018- Thriving Aquaculture Sector to Accelerate Growth’ by Ken Research

The report provides detailed overview on compound feed, concentrate feed and premixes and additives, in addition to feed for specific animal species in China and helps readers in identifying the ongoing trends in the key segments of the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report will aid industry consultants, animal feed companies, marketing companies and other stakeholders to align their market centric strategies according to ongoing and expected trends in future.

Read More:

Contact Person: Ankur Gupta
E-mail:

Dental Devices Market To 2016

Posted on by admin

The global market for dental devices is forecast to exceed $12.9 billion by 2016 with a Compound Annual Growth Rate (CAGR) of 9% from 2009 to 2016. The market is expected to be driven by strong demand for dental implants in US, Japan, Germany and France. The changing dynamics of patient choice and demand for cosmetic dentistry will drive the dental devices market. In addition,technological advances, increased preference for minimally invasive surgeries, dental benefit plans and direct to consumer advertising by manufacturers are also expected to bolster the growth in the global dental devices market.

For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Dental-Devices-Market-to-2016-Cosmetic-Dentistryand-Dental-Implants-to-be-the-Key-Growth-Drivers&ReportType=Industry_Report&Title=Medical_Devices

The market for dental devices in China is forecast to grow at CAGR of 15% for the next seven years from 2009-2016. The market is expected to be mainly driven by healthcare reforms and deregulation of dental services in China. The state council of china announced an allocation of US$123 billion as part of its new medical reform plan to improve health care through 2011. The plan would cover 90% of Chinas population under a universal health care system by 2010 to significantly improve health care facilities and expand health related infrastructure. Developing Chinese economy has led to consumers desire for better health care and higher quality dental services. This has resulted in rapid expansion of dental clinics, which are expanding beyond basic dental care to offer higher value added services. There are more than 1,000 dental laboratories in
China with production permits and more than 50% of all dental lab equipment and materials are imported from overseas. Health care facilities needs to be equipped with advanced dental technologies as 60% to 70% of current equipment is from the 1970s or 1980s.Hence, patients are seeking out advanced dental techniques to treat there illnesses., which will increase the demand for dental devices.

The US is the biggest market for dental devices, having a market share of 37% towards the global dental device market in 2009. In that year the US dental market was valued at $2.2 billion which is forecast to grow at a CAGR of 10% to reach $4.2 billion by 2016 .In 2008, the U.S. healthcare spending rose to $2.3 trillion. According to Centers for Medicare & Medicaid Services (CMS) $2.3 trillion spent on healthcare in 2008 is translated to $7,681 per person. The baby boomer population due to their unhealthy lifestyle has been contributing significantly to the dental devices market growth in the US. . Implant manufacturers conduct training sessions for dentists to increase awareness, which will drive the dental devices market. Increase in demand for specialist clinics will
bolster the growth of dental implants, chairs and equipment category.

GBI Researchs report, Dental Devices Market to 2016 Cosmetic Dentistry and Dental
Implants to be the Key Growth Drivers provides key data, information and analysis on the global dental devices market. The report provides a market landscape, competitive landscape and market trends information on six dental devices market categories: crowns and bridges, dental chairs and equipment, dental lasers, dental implants, dental biomaterials and dental radiological equipment.The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the latest, advances in dental devices market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of
industry experts.

For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Dental-Devices-Market-to-2016-Cosmetic-Dentistryand-Dental-Implants-to-be-the-Key-Growth-Drivers&ReportType=Industry_Report&Title=Medical_Devices

Visit our report store: http://www.gbiresearch.com

For more details contact:
[emailprotected]
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

Chinese Herbs Can Treat Lung Cancer With Cough Up Blood

Posted on by admin

Lung cancer is the most common primary cancer, most tumor cells originated in the bronchial epithelium. if the people appear the Symptoms for Long-term coughing, blood tinged sputum, chest pain and fever, should pay more attention to healthy. Those are the early signals of lung cancer. The treatment of lung cancer Symptoms of cough up blood. Chinese medicine function: qi righting, detoxification eliminate cancer, lung cancer and effective. Chinese herbs anticancer xiaoliutang is a kind of specific drugs for lung cancer treatment. It can help patients Immunity restoring the internal organs function , eliminating boycott, reach the purpose treating both the incidental and fundamental aspects simultaneously. However, in many cases, significant improvement can be made in 10 to 15 sessions. it can effectively treat cough up blood. Chinese herbs anticancer xiaoliutang has many advantages in the treatment of cancer.

Cancer Cells grows on the growth of lung tissue in the bronchus, Usually produce respiratory irritation occurs irritating cough. Like some other cancers, often does nt produce symptoms until it is too late and has spread beyond the chest to the brain, liver or bones. It can be hard for even a trained doctor to spot the symptoms of the cancer. Peripheral Tumor cells because the tumor grew in the peripheral lung, resulting in fewer symptoms, not even cough. Surgery, radiotherapy and chemotherapy damage the body’s immune system is obviously not suitable for the older or poor health patient, Under conservative treatment. Chinese medicine with out side effects and effects were stable for patients. The Chinese medicine treatment can supplement the deficiency of modern medicine, and correct the impair in the treatment process of modern medicine. We used traditional Chinese medicine combined with chemical drugs to treat cancer of lung, so as to increase the remission rate of the cancer. TCM treat lung cancer can supplement the deficiency of modern medicine, and correct the impair in the treatment process of modern medicine.

It is the natural herbs are through simple processing, drying and fine grinding. Chinese medicine formulates individual treatment plans according to the state of illness, supplemented with psychological guidance and therapy. That reflect Chinese medicine cure the disease dialectically, there is a unique advantage in stability of curative effect. The patients will use the external treatment while taking the internal treatment. Integration of treating the body as a whole and local treatment. “Fighting the symptoms” and “curing the disease” are not new concepts in China, Chinese herbs anticancer xiaoliutang can administer thoroughly And has a unique effect.

Functionality Of Hardy Rubber Tree – Drink Eucommia For Physical And Mental Health

Posted on by admin

The hardy rubber tree is an unusual plant which was first found in central China. It can reach as high as 60 feet in the warmer climates of the world. The technical name for the tree is called Eucommia ulmoides, and the tree contains latex or gum. Eventually, the bark of the tree was used for medicinal or health purposes. The extract is considered to be of balanced and acrid consistency and has been historically used in an oriental tea or Chinese tea blend. Traditionally, anywhere from 7 to 10 % of a medicinal tea will consist of extract from Eucommia ulmoides.

The hardy rubber tree must be at least 10 years old before material is suitable for harvesting. The trunk bark is typically gathered between April and June in three large sections. During these spring months, the potency of the medicinal elements is at their highest. To process the extract, the bark is folded in on itself, with the inner surfaces touching each other. The bark is then left for several days until the inner areas turn black. The next step is to allow the bark to fully dry via sunlight exposure after the outer layers of bark are removed. During growing months, the tree’s living bark is cracked regularly to expose and collect white latex threads.

Eucommia serves to treat mainly ailments when prepared in oriental tea or Chinese tea. It is used as a detoxification element and promotes kidney cleansing, colon cleansing and urinary tract health. Reduction of genital itching is also a known benefit of the hardy rubber tree plant. As an overall detoxification agent, Eucommia will assist with expelling toxins from the blood. It will also aid in boosting the overall immune system, effectively helping the body to fight off disease and illness.

Medicinally, Eucommia is used to treat lower back pain and knee pain. Deficiencies in strength of the lower body can be attributed to kidney and liver health. Eucommia cleanses the liver and kidney which in turn strengthens the lower body. The oriental tea or Chinese tea made from the hardy rubber tree plant will also promote joint lubrication and functionality as well as bone strength and health. Eucommia is said to have age defying properties when used regularly and used to make its drinkers light of mind and light of age. Finally, drinking teas made with Eucommia can promote weight loss and long-term weight management.

Heart Health Hawthorn Berries Natures Tonic for the Heart

Posted on by admin

In the first century, the Greek herbalist Dioscorides wrote about the health-giving properties of the berries of the white-thorn, or hawthorn tree. Thereafter, Romans, Greeks and even Renaissance herbalists utilized the rose-like petals and red berries of the hawthorn tree as a powerful tonic for heart health.

In modern Europe, doctors regularly prescribe hawthorn extract to alleviate a variety of mild to moderate heart related symptoms. Hawthorn is listed as an official drug in the Pharmacopoeias (official drug compendium) throughout China, Europe and South America, as an effective treatment for heart ailments and cardiovascular disease. It is used in cases of angina pectoris (chest pains), arrhythmias (abnormal heartbeat), aged related cardiac insufficiency, arteriosclerosis and to regulate both high and low blood pressure.

European studies indicate that hawthorn can reduce strains on the heart by dilating peripheral blood vessels (lowering blood pressure), while it simultaneously increases cardiac output as it strengthens the contractility of the heat muscle (allowing it to pump stronger). Angina cases are often relieved because it is believed to dilate coronary blood vessels, increasing the oxygen supply to the heart muscle. This may reduce the risk of having a heart attack and increase your chances of survival if one does occur. Studies have also shown hawthorn to speed the recovery of those who have suffered a heart attack.

Hawthorn berries contain cardiotonic amines, polyphenols and vitamin C with significant amounts of bioflavonoids. Universally considered to be safe even in long term use, hawthorn is non-toxic, not habit-forming and does not appear to interfere with any conventional medications. It is sometimes given concurrently with much more toxic allopathic medicines to reduce the dosage and necessity of the drugs. Over a dozen clinical trials have concluded that hawthorn berry extract can be a safe and effective option in cases of chronic congestive heart disease.

Hawthorns valuable clinical effects include:

A powerful antioxidant free-radical scavenger to reduce the plaques of atherosclerosis

An arterial dilator to infuse more oxygen-rich blood to the heart muscle, alleviating angina (chest pains) while lowering peripheral blood pressure

An anti-arrythmic (steadies the heart beat by stabilizing the hearts rhythmic contractions) to prevent deadly, vessel-plugging clots

A cardiovascular tonic which increases cardiac output and endurance

Is mildly sedative, reducing some of the nervousness associated with angina or palpitations

Hawthorn taken in conjunction with other heart healthy supplements like vitamin E, Co Q10 and omega-3 fats (from fish oils), is a ideal way to support longevity, endurance and preventive heart health at any age.

© 2025 Force Health Care